| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-06-18 07:49 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,884
+361 vol $5.22 each |
45,597 | |
| Filed 2026-06-18 07:48 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,199
+876 vol $9.36 each |
45,236 | |
| Older filings | ||||||
| Filed 2026-03-27 17:24 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$38,184
+6,061 vol $6.30 each |
18,344 | |
| Filed 2026-03-27 17:15 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$76,368
+12,122 vol $6.30 each |
36,688 | |
| Filed 2026-03-27 17:13 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,273
+16,710 vol $6.30 each |
99,810 | |
| Filed 2026-03-27 17:11 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$59,580
+9,295 vol $6.41 each |
44,360 | |
| Filed 2026-03-27 17:09 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-47,774.40
-10,760 vol $4.44 each |
24,566 | |
| Filed 2026-03-27 17:07 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-23,887.20
-5,380 vol $4.44 each |
12,283 | |
| Filed 2026-03-20 15:39 Tx date 2026-03-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,574
+297 vol $5.30 each |
35,065 | |
| Filed 2026-03-20 15:38 Tx date 2026-03-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,910
+1,120 vol $6.17 each |
34,768 | |
| Filed 2025-12-19 14:17 Tx date 2025-12-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,835
+353 vol $5.20 each |
33,648 | |
| Filed 2025-12-19 14:17 Tx date 2025-12-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,062
+1,337 vol $6.03 each |
33,295 | |
| Filed 2025-09-17 15:54 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,573
+356 vol $4.42 each |
31,958 | |
| Filed 2025-09-17 15:52 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,913
+1,082 vol $6.39 each |
31,602 | |
| Filed 2025-06-18 16:31 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,810
+368 vol $4.92 each |
30,520 | |
| Filed 2025-06-18 16:30 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,009
+1,326 vol $6.04 each |
30,152 | |
| Filed 2025-04-04 18:47 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$31,448
+5,097 vol $6.17 each |
28,826 | |
| Filed 2025-04-04 18:45 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-45,498.93
-8,733 vol $5.21 each |
35,326 | |
| Filed 2025-04-04 18:43 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-22,752.07
-4,367 vol $5.21 each |
17,663 | |
| Filed 2025-03-29 16:22 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$37,427
+6,027 vol $6.21 each |
22,030 | |